Infectious disease
Evelo Biosciences, along with Rutgers University and Robert Wood Johnson University Hospital, is driving toward a Phase II study of an investigational treatment for hospitalized patients with newly diagnosed COVID-19.
It is important to remember that this is a new virus, so researchers are constantly learning more about it every day.
Vaccine expert Rick Bright, who was abruptly dismissed from his post as director of the Biomedical Advanced Research and Development Authority (BARDA) last month, filed a whistleblower complaint against the administration over its failures to heed warnings about the COVID-19 pandemic and accused the White House of cronyism in awarding contracts.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 6, 2020.
Luminex, a developer of molecular diagnostics and clinical tools for the life sciences industry, returned to profit this quarter – well ahead of schedule – after a major client, LabCorp, departed in 2019.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.
Leaders from all over the world met for a virtual summit on Monday, May 4 to pledge billions of dollars to fund development of a vaccine against COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Noticeably absent was the United States.
The Hill reports that the six or eight selected will go into clinical trials, where “health experts are looking to weed out faulty candidates and come out with three or four vaccines that clear final testing to be used by early 2021.”
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 4, 2020.
intravenous immunoglobulin is a common blood plasma product that is used to treat other immune disorders. Scientists are hoping to use it for COVID-19 treatment.
PRESS RELEASES